Project Details
Description
An open-label Phase I trial to evaluate the pharmacokinetics and safety profile of BAY 94-9027 following single and multiple dose administration in two cohorts of previously treated male subjects with severe hemophilia A
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/10 → 5/31/13 |
Funding
- BAYER HEALTHCARE PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.